China Modern Agricultural today released its projected earnings for the fiscal year ending June 30, 2012. The company’s forecasted net income will have increased by 86% year-over-year to $16.4 million, or $0.35 per basic and diluted earnings per share.

China Modern’s revenue for the first three quarters of fiscal year 2012 was $19.5 million, which represents an increase of $2.3 million, or 13%, as compared to $17.2 million for the three quarters ended March 31, 2011. The company’s gross profit increased by $4.4 million, or 52%, to $13 million. The gross profit margin has improved from 50% to 67% as compared to the same period last year. These increases are primarily due to the company’s adoption of a new business model, which provides China Modern with a revenue stream that incurs very little direct cost, thus improving the gross profit margin.

In November of 2011, China Modern successfully acquired 100% ownership of Shangzhi Yulong Cattle Industry Co. Ltd., generating a bargain purchase gain of $5.72 million that has been consolidated in the quarterly financial statements ended Dec. 31, 2011.

For the three quarters ended March 31, 2012, China Modern’s net income increased by $8.4 million, or 149%, to $14 million, as compared with $5.7 million for the three quarters ended March 31, 2011. The company’s net profit margin increased from 33% to 72%, and the earnings per share increased from $0.14 to $0.31, which was an increase of $0.17 or 120%.

The company’s projected earnings for the fiscal year ended June 30, 2012 are anticipated to be approximately $27.6 million, which represents an increase of $2.6 million, or 10%, as compared with $25 million for the same time frame in the previous year. Revenues from raw milk sales are forecasted to be $18.3 million, and sales commission from farmers is projected to be $9.3 million. The company’s forecasted gross profit is $18 million, which is an increase of $5 million, or 38%. The gross profit margin is anticipated to increase from 52% to around 65%. China Modern’s anticipated net income is $16.4 million, which represents an increase of around $7.6 million, or 86%, as compared to the same period in 2011. The company’s projected net profit margin will have increased to 59%, up from 35%, and the earnings per share is forecasted to rise from $0.23 to about $0.35, which is an increase of 52% year-over-year.

China Modern Agricultural is a high-tech livestock company that specializes in breeding cows and calves, producing and selling milk, and selling organic fertilizer directly to suppliers. The company additionally provides livestock breeders with specialized livestock technical consultation, cow breeding technical support, and agricultural information support. The company’s farmland is located in the Heilongjiang Province, which has a humid continental climate that is ideal for the growth of grass, which, in turn, is essential for grazing and feeding cattle and aids in the company’s cow and calf breeding, raw milk production, and organic fertilizer production.

For more information, visit the company’s Web site at www.hljzhongxian.com/zx/eng_zx/index.asp

Let us hear your thoughts below:

ActiveCare, a wellness company, is the service leader in telehealth and personal emergency response and was the first company to combine an emergency cellular device with GPS tracking technology. Headquartered in Salt Lake City, the company offers the latest technology and the highest level of care to its clients, helping with both emergency situations and everyday needs.

ActiveCare’s care center is staffed 24 hours a day, seven days a week by trained specialists offering varied assistance, from emergency help to health monitoring and concierge services. Members reach the CareCenter through the company’s patented, one-button emergency cell phone, Personal Assistance Link (PAL). PAL utilizes cellular, GPS, and automatic fall detection and is a handheld, wearable device. ActiveCare’s other technologies include the ActiveHome, the ActivePortal, and the ProActive Care discharge planning solution.

ActiveCare is the service leader in virtual care for persons who are elderly, disabled, and/or chronically ill, giving its members the care and solutions they need to remain active and independent. Over the past decade, the company has also become the leading provider of location tracking technology.

Let us hear your thoughts: ActiveCare, Inc. Message Board

EGPI Firecreek today announced serious Q2 momentum drivers, including projected development activities on the 240-acre Boyette Lease, development on the South 40, the completion/sale of 50% of the North 40 interests in their J.B. TUBB Lease, Inc., and sale of their 51% majority interest in Arctic Solar Engineering. EFIR currently operates via wholly-owned subsidiaries, with oil and gas services handled by Chanwest Resources, LLC and resource acquisition through Energy Producers, Inc.

Needless to say it’s been a huge Q2 over at EFIR and projections indicate substantial development activity for the remainder of the interval, with elements like the (previously announced) signing of a Letter of Intent with Cubo Energy, PLC to kick off drilling programs in West Central Texas, as the pair goes after rich Barnett Formation targets. Looking at as little as 10-14 days before definitive agreements with an assignee of Cubo are rendered and then an extensive 3D seismic surveying agenda designed to quantify the 240 acre Boyette site down in Shackelford County, TX.

EFIR also signed a key agreement with Cubo back at the start of March this year, making a $1.15M sale of North 40 oil and gas interests in the J.B. Tubb Leasehold Estate (currently in restructuring due to recent regulatory changes on the Frankfurt Stock Exchange, interest assignments via definitive long form agreement projected within a 10-14 day window). This agreement will place Cubo (or an assignee) in a financing role for the initial sinking of an 8.3k foot well targeting the Ellenburger Formation (on an earn-in basis), as well as setup the framework for additional, planned infrastructural development/participation via an earn-in/financed basis (projected initial CAPEX of some $1.575M).

CEO of EFIR, Dennis Alexander, cited the regulatory environment on the Frankfurt Exchange over the last six months (leading to several unforeseen delays) as the primary mover behind the modification of their agreement with Cubo, reassuring shareholders that requisite changes have since been formulated, and that the clear forward direction established for this relationship has energized both parties.

This relationship will help to facilitate the planned activity in West Central Texas, as Cubo and EFIR pursue specific Barnett Shale characteristics mapped via the 3D seismic work. The receptivity is strong on all accounts, especially geologically speaking, and both companies are eager to get 1-2 horizontals (or an equivalent 8 verticals) in on the Boyette lease as soon as possible.

Mr. Alexander underscored the significance of the drilling programs aimed at developing the Ellenburger Formation, the seismic work being done, and preparatory vectors for realizing some serious Barnett action.

In addition to all this hydrocarbon effort, EFIR announced signing of a Letter of Intent with W2 Energy, Inc., covering the sale of the company’s 51% majority interest in subsidiary Artic Solar Engineering, Inc. (definitive agreement projected within 7-10 days). Mr. Alexander noted the completion of required/audited year-end and unaudited Q1 financial statements by both parties, offering the market a sound benchmark of the deal, as well as projecting a long, healthy relationship between both parties moving forward.

For more information on today’s announcements, or to find out more about EGPI Firecreek, Inc. please visit the company’s website at: www.EGPIFirecreek.com

Let us hear your thoughts below:

GreenWorld Development is an American-Irish waste-to-energy operating company. It is dedicated to develop innovative, competitive, and sustainable products for efficiency goods and services and to support the growing “green” economy.

The company announced today that it has signed a binding framework agreement to acquire Natures Earth LLC, a wood pellet manufacturing facility in North Carolina for a proposed acquisition cost of $16.5 million. Wood pellets are a major source of alternative energy for industrial and domestic use. The capacity of the facility is 120,000 metric tons of wood pellets. This amount is projected to be capable of producing annual revenues in excess of $20 million for GreenWorld Development.

This acquisition is the first cornerstone in the company’s projected expansion plan of “build-own-operate waste-2-energy” plants both in the United States and Europe. GreenWorld plans to double the capacity of the plant within one year and is currently in advanced discussions with a realistic long term production offtaker and feed stock provider. It is at the moment in the process of raising capital, via a long-term financing bond, from a major US financial institution.

The acquisition agreement includes the Equine Pine & Freedom Fuel brands owned by Natures Earth LLC. Once the acquisition closes, GreenWorld intends to appoint Jason Kessler of Kesco and Bliss Industries LLC as the project manager. He has many years of expertise and experience in this industry.

For additional information about GreenWorld Development and this acquisition, please visit the company’s website at www.greenworld-global.com

Let us hear your thoughts below:

It was surely one of the most highly publicized IPOs in history. It was one of the reasons that, on Friday, when Facebook shares went out to the world, and share price closed at an unexciting $38.06, the party was largely already over. Bidding had long since catapulted Facebook into the stratosphere, driving its paper value higher than some analysts think the company will ever be able to justify. It perhaps makes little difference to the average investor, someone who was never invited to this particular party anyway. This was a game that was being played mostly by long-standing insiders, and yesterday was more of a payoff day than anything.

And you have to consider the IPO’s timing. Given the state of the U.S. and world economy, there’s even less to be excited about, unless you think that perhaps unemployed Europeans will spend more time on Facebook because they don’t have anything else to do. Moreover, the fact that giant IPOs such as this can generate enough volume to overpower computers responsible for processing the trades, causing significant slowing and frustrating would-be investors, is another problem. Many things have changed since the market crash of 1987, a disaster that many feel was fueled at least in part by glitches in the still struggling field of computerized trading, but there are still significant weaknesses to overcome that don’t show up until unusual volumes or other factors collide. Some firmly believe that such dependence upon electronics (think computer dominated NASDAQ) is like living in a house of cards, and that someday there will indeed come the perfect storm.

What all of this says about Facebook the company is less clear. It’s easy to discount the hype surrounding an IPO, but, like it or not, Facebook, according to the New York Times, points to more than 800 million active users around the world, with roughly 200 million in the U.S. The future value of that is not so easily discarded.

Let us hear your thoughts below:

InVivo Therapeutics Holdings recently announced that the company’s CEO, Frank Reynolds, is scheduled to make appearances on two television news programs. The appearances will occur on Saturday, May 19, and Sunday, May 20, on the channels KXAN-TV and WXYZ-TV, respectively.

Founded in 2005, InVivo is a Cambridge, MA-based company focused on developing technology using polymers to assist patients who are paralyzed from spinal cord injury. InVivo was founded by Robert S. Langer, ScD. Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital. The company won the 2011 David F. Apple Award for its outstanding contribution to spinal cord injury medicine.

Reynolds will be discussing InVivo’s new polymer-based treatment that uses a scaffold to provide structural support to a damaged spinal cord, preventing the spinal cord from scarring. Reynolds will also discuss new products under development by InVivo, such as hydrogel technologies. Reynolds’ first TV appearance will be on Austin News Today Weekend, which airs on Saturday, May 19 at 7:20am CDT on KXAN-TV, the local NBC affiliate for the greater Austin, TX area. The second appearance will be on 7 Action News This Weekend, which airs Sunday, May 20 at 8:40am EDT on WXYZ-TV, the local ABC affiliate in Detroit, MI.

“Our technology is a true platform that can be leveraged to create many Neurotrauma products. InVivo is developing technologies to treat chronic injuries like Drew’s, as well as therapies for other nervous system conditions such as chronic pain due to nerve compression and other peripheral nerve injuries. We’re currently under review at FDA for our first SCI treatment, and we look forward to receiving approval to begin those human studies in 2012,” said Reynolds.

Let us hear your thoughts below:

Advanced Cell Technology, a leader in the field of regenerative medicine, announced that chairman and CEO Gary Rabin will be delivering a presentation at the World Stem Cells and Regenerative Medicine Conference, May 21-23, in London, a conference held to promote discussion and collaboration in the stem cell and regenerative medicine industry.

Mr. Rabin’s presentation will be given today at 5:05 p.m. BST (London time). It is titled “Successes and ongoing advancements of human clinical trials for the treatment of AMD & Stargardt’s Disease.” Mr. Rabin’s presentation will detail progress on ACT’s three ongoing human clinical trials in the U.S. and E.U. for Dry Age-Related Macular Degeneration and Stargardt’s Macular Dystrophy (SMD).

In addition, ACT recently announced it has received Data and Safety Monitoring Board approval to advance the enrollment and treatment of additional patients with SMD in its U.S. SMD trial, as well as to treat the remaining two patients to finish up the initial dosing arm in its European trial. Every one of the company’s ongoing clinical trials use human embryonic stem cell derived retinal pigment epithelial cells.

For more information, please visit www.advancedcell.com

Let us hear your thoughts below:

Friday, Real Estate Contacts announced that it has expanded its online social media campaign, choosing Facebook as the primary social media channel. Real Estate Contacts believes Facebook offers an unparalleled marketplace for home sellers and homebuyers to easily get market and home information through a communication method with which they are familiar.

“Our research and testing has shown Facebook is a great match for our real estate demographic of real estate agents, brokers, homeowners and individuals looking to purchase homes,” commented Robert DeAngelis, President and CEO of Real Estate Contacts. “There are multiple social media platforms available – Google +, Twitter, MySpace, Ning and LinkedIn to name a few. But, we believe Facebook offers the best return on investment for our marketing dollar as well as a platform for continued communication with our clients and prospects.”

Facebook has several key functions that will help Real Estate Contacts connect the real estate broker, buyer, and seller social eco-system. Wall posts allow users to communicate with clients and friends; news feed management allows REAC and its users to receive as much or as little information and updates from the real estate topics that they choose; the photo and video upload tool provides an inexpensive way to communicate with a large or small database quickly and easily; and, realtors can capitalize on traffic by posting information and links through the posted items feature.

“Facebook has 900 million users. Over 500 million login in everyday. That’s just too big to ignore and REAC is taking advantage of this global opportunity,” continued Mr. DeAngelis. “The functionality and ease of use is proving to be a winner with our growing user base.”

Let us hear your thoughts below:

TransBioTec, maker of a revolutionary alcohol sensing system for vehicle access control, today announced the appointment Scott Painter to the position of Chief Executive Officer. Mr. Painter has a highly successful track record as an experienced CEO, growing businesses, raising capital, developing management teams, forming strategic partnerships, in addition to mergers and acquisitions.

The appointment, officially made by the Board of Directors May 1, 2012, is in conjunction with the development and deployment of TransBioTec’s new transdermal alcohol sensing technology, called SOBR. The patented system combines a non-invasive alcohol sensing technology with an ignition interlock system that functions through transdermal biometric feedback. SOBR senses ethanol alcohol via sweat secretion from the hands. The blood alcohol detection technology and the ignition interlock device are connected through a microprocessor. The result is the first product on the market that is neither intrusive nor invasive, able to be fitted to any vehicle while keeping crucial aesthetic appeal for the general population. As such, it offers a unique solution to the national drunk driving epidemic.

Scott Painter has an impressive career of building business, beginning out of college in the insurance industry where he worked in Seattle for Sun Life of Canada, the world’s 10th biggest insurance company. He took the Seattle agency from 52nd place out of the company’s 55 agencies to 4th place, making it one of the company’s most successful agencies.

He then created Painter Financial Group, Ltd., a retail broker/dealer, which he grew as CEO from a startup to 50 offices nationwide, with 485 brokers and $80 million in sales. He then sold the company to UK’s Bekhor International.

Scott then co-founded and served as Managing Partner of Chanen Painter & Company, Ltd., a boutique investment bank in Seattle. The company managed financings for a wide variety of technology enterprises and other businesses, a number of which are today traded on the NASDAQ exchange.

In addition, as CEO of Bogart Golf, a retail indoor golf training firm, he raised venture capital, built out a management team, opened 16 training centers in four states, and took the firm to profitability in 22 months. He later helped a team with another company in commercializing architecture for networking and VoiP, becoming company Chairman and CEO, creating a business strategy, recruiting management, and raising $5 million to establish the company’s sales and revenue stream.

Let us hear your thoughts below:

Today, affordable housing and structural insulated panels (SIPs) manufacturer Aquentium, Inc. announced it is seeking joint venture partners for affordable housing projects across South America.

Aquentium’s affordable homes are designed to be built with SIPs, which are a composite building material consisting of an insulating layer of rigid polymer foam pressed between two layers of structural board. The board can be sheet metal, plywood, cement, or oriented strand board (OSB), and the foam can be expanded polystyrene foam (EPS), extruded polystyrene foam (XPS), or polyurethane foam.

Sharing the same structural properties as an I-beam or I-column, SIPs have a rigid insulation core that acts as a web, while the OSB sheathing has the same properties as the flanges. SIPs combine several conventional building components, such as studs and joists, insulation, vapor barrier and air barrier, and can be used for a variety of applications, such as exterior wall, roof, floor, and foundation systems. Using SIPs brings many benefits compared to a conventional framed building, and SIP panels are approved for construction use by ICC.

Using SIPs when building a home results in a tighter building envelope and walls with higher insulating properties, leading to fewer drafts and a decrease in operating costs. Due to the standardization and all-in-one nature of SIPs, construction can take less time than for a frame home and requires fewer tradesmen. SIPs can be used in floors, walls, and roofs, and using the panels as floors is particularly beneficial when used above an uninsulated space. The total lifecycle cost of a SIP-constructed building is generally lower than in a conventional framed building, and some reap lifetime savings as high as 40%. Certain circumstances, such as local labor conditions, will affect whether this benefit is realized on total construction cost alone (materials and labor).

Those interested in a joint venture or representing the Aquentium technologies in the U.S. or internationally should contact the company.

Aquentium is focused on bringing energy-saving solutions and technologies to companies and countries across the globe. Aquentium is involved in waste-to-energy, solar energy, water treatment, non-chemical sanitation equipment, recycling, SIPs, affordable housing, re-deployable/emergency housing, and recycling. Aquentium is also engaged in an ongoing effort to acquire or invest in new technologies and businesses.

For more information, visit the company’s Web site at www.aquentium.com

Let us hear your thoughts below:

Today, Heavy Earth Resources, an oil and gas E&P focused on underexplored regions, such as the hydrocarbon basins in Central/South America, reported that the company has acquired the sole, issued share of a Colombia-focused company based in Barbados, also offering an update on extant operations (includes a withdrawal/transfer agreement and seismic program).

HEVI made the acquisition via a purchase and sale agreement through Heavy Earth’s Deep Core, Inc. subsidiary, for the sole issued share of Petro Vista Energy Colombia (Barbados) Corp., whose operations include a working interest in the Lower Magdalena Valley Basin, La Maye E&P Contract.

In addition HEVI, through the company’s Colombian operating subsidiary (DCX SAS), entered withdrawal/transfer agreements (closed May 15) with SK Innovation Co. Ltd (out of Korea) and Petroamerica International Corp. (Panama) for the SSJN-5 E&P Contract. This move places HEVI in a better logistical position, where the company can exploit its lower risk exploration vectors, while opening up underexplored resource areas that have tremendous potential for future production.

CEO of HEVI, Grant Draper, pointed to both of these moves as a prime example of the company’s capacity to generate shareholder value by growing the fundamentals. Draper explained that such acquisition of “highly probable and profitable working interest assets” via its subsidiaries, in what are emerging regions with proven hydrocarbon geology, as well as production track records, places HEVI in a solid acreage position to drive both future growth of shareholder value and raw output.

They key target being looked at here is the La Maye Block (testing well Noelia-1 already sunk back in Oct of 2009 and awaits testing), a some 68.3 gross acres of choice territory with perfect geologic analogs to the proximal, producing, Cienaga de Oro (sandstone target) and Cicuco (reefal limestone in and around granite) formations. La Maye is updip from the Cicuco & Boquete Fields and is primarily characterized by highly porous sandstone and shallow water.

Additionally, the company offered information on overall operations for Colombia, including the completion of 3D seismic analysis data capture (and subsequent commencement of data processing) on the northern part of the Morichito Block (designed to extend and refine extant 2D survey data, helping to quantify the resource footprint of the two primary, high-value prospects in among the multiple potential targets).

Also covered among the operational update was a declaration of commercial viability status for the company’s Morichito-5 discovery well, as well as that start of creating the requisite logistical infrastructure required to take the Morichito-5 into production some time in Q1/Q2 2013.

Let us hear your thoughts below:

Bonds.com Group, through its subsidiary Bonds.com, serves institutional fixed income investors. The company provides a comprehensive, zero subscription fee online trading platform for corporate bonds. It also provides a global solution for trading small lot corporate bond inventories electronically.

Bonds.com Group announced today the appointment of a new chief executive officer effective June 1, 2012. His name is Thomas M. Thees, and he is currently a member of the firm’s Board of Directors. This is obviously a key appointment and comes at a critical time in the development of Bonds.com.

Mr. Thees brings 30 years of industry expertise and experience in building traditional and electronic fixed income businesses and operations. He most recently served as head of investment grade credit and former co-head of fixed income at Jeffries & Company, and previously served as chief operating officer of MarketAxess Holdings. In addition, Mr. Thees spent over two decades in senior management positions at well-known Wall Street firms such as Morgan Stanley, Goldman Sachs, and Citigroup.

Bonds.com is poised to grow in the current financial environment based on the evolution of the structure of the fixed income market. Markets trends including the move by investors toward fixed income instruments and increasing demand for real-time electronic trading, access to liquidity, global execution across asset classes, and regulatory changes (such as implementation of the Volcker rule) indicate an abundance of opportunities for Bonds.com.

The company’s BondsPRO platform provides professional traders over 70 thousand live prices, with 85 million price updates daily, on 10 thousand different bond issues from over 300 contributing counterparties. BondsPRO also posts live, anonymous, and executable orders on a single bond or list basis, and permits price negotiation.

For further information about Bonds.com, please visit the company’s website at www.bonds.com

Let us hear your thoughts below:

In uncertain times, when the future of the economy is less than clear, it’s not surprising that businesses turn to outsourcing to fill production gaps. Outsourcing, first and foremost, means flexibility, freedom from the economic commitments inherent in operational scale-ups. In short, it’s something of a hedge against future downturns. If business heats up, you can increase your outsourcing. If business cools down, you can cut back without painful layoffs. But flexibility is only one of the benefits of outsourcing, which is why an increasing number of companies, including large global enterprises, are turning to companies like Beacon Enterprise Solutions.

Beacon, a global IT services provider, is a great example of IT outsourcing’s other key benefit. Specifically, it places at your fingertips the most advanced technologies and the most skilled technical professionals, when your company, or one of its operations, is unable or unwilling to build its own in-house IT base. One of the most basic rules of business is to maintain a focus on your core strengths, and nothing can distract attention and drain corporate energy faster than trying to keep up with the constantly morphing world of Information Technology. By leaving the headaches of IT to the IT professionals, the full force of a company’s resources can be directed at what it does best.

This requires a form of partnership with your IT provider that is rare in the industry, but it is one of Beacon’s greatest strengths. Beacon makes a point of developing long-term relationships with its corporate clients, teaming with its customers to make the kind of IT decisions that will continue to pay off for years to come. Beacon represents not only flexibility, but a mutual commitment to the future. It’s why Beacon has been able to work with demanding corporate giants like Merck, Volvo, and UPS, and why Beacon continues to be highly successful.

For additional information, visit the company’s website at www.AskBeacon.com

Let us hear your thoughts: Beacon Enterprise Solutions Group, Inc. Message Board

Yesterday, Ambient Corporation, a leader in providing flexible and scalable smart grid communications platforms and technologies, announced it has taken its first step into the European market with a trial of its Power Quality Monitoring application and energy sensing equipment.

Part of the Low Carbon Networks Fund, overseen by U.K. regulator OFGEM, the trial is being conducted by U.K. distribution network operators (DNOs), Western Power Distribution, and U.K. Power Networks. The trial is focused on evaluating low voltage current sensor technologies and how network operators can utilize them in running their grids.

Being selected for participation in this project represents a key step for Ambient, as the company ventures into new geographies with significant potential. By deploying Ambient’s communications platform with its internally developed software applications, DNOs have the capability of performing real-time current and voltage sensing, generating valuable data for monitoring their distribution networks and substations.

The participation of Ambient and other companies in this project will provide a clear understanding of the technologies available for Low Voltage Network monitoring. This will give essential data, allowing for greater visibility of the Low Voltage Network and, subsequently, facilitate smart networks.

The Power Quality Monitoring application is part of the Ambient Smart Grid Communications Platform, which facilitates multiple smart grid applications, in parallel, and is capable of using various communications simultaneously.

Ambient Corporation is engaged in designing, developing, and selling the Ambient Smart Grid communications platform, with products and services including communications nodes; AmbientNMS, a network management system; integrated applications; and maintenance and consulting services to help utilities save on operational costs. Ambient uses open, standards-based technologies and in-depth industry experience to provide utilities with solutions for their smart grid initiatives.

For more information, visit www.ambientcorp.com

Let us hear your thoughts below:

Zix, the leader in email encryption services, announced the release of a new and improved version of ZixPort®, a secure Web portal. This upgraded version includes message recall and two-factor authorization, providing increased control and flexibility of encrypted email messages to compliance and security officers.

ZixPort is a delivery method that enables bidirectional email encryption for recipients who do not have ZixCorp® Email Encryption Services. ZixPort is available to any recipient with an Internet browser, and can be easily accessed on mobile devices as well. The message recall feature gives compliance, security officers, and administrators the ability to remove messages from ZixPort if an email is sent to the wrong recipient or the wrong file is mistakenly attached.

The second new feature in this release of ZixPort is two-factor authentication in a streamlined, user-friendly process that is perfectly suited for financial institutions and government organizations that require additional security without inconveniencing recipients. This new authentication method will be the third authentication method offered with ZixPort, along with integration with customer’s existing Single Sing-on technology and solutions from third-party two-factor authentication providers.

“ZixCorp has set the bar in industry-leading email encryption services. We are constantly investing in our products to ensure that we exceed customer demands, as well as meet our commitment to deliver innovative, easy-to-use secure email,” said Rick Spurr, ZixCorp’s Chairman and Chief Executive Officer. “ZixPort is an essential delivery method in our portfolio of services, and the new features of ZixPort enhance control and flexibility for our customers and continue to extend our lead in the market.”

The new message recall feature is scheduled to be rolled out in June 2012. Two-factor authentication is expected to be commercially available in August 2012. For additional information, please visit ZixCorp’s booth – no. 85 – at the Gartner Security & Risk Management Summit on June 11 – 14, 2012, or contact 866-257-4949.

For more information, please visit www.zixcorp.com

Let us hear your thoughts below:

Today, Zynex, a developer of advanced non-invasive devices for a variety of medical functions ranging from cardiac monitoring and electrotherapy, to neurological diagnosis and actual stroke rehabilitation, was pleased to announce that the Ernst & Young Entrepreneur of the Year® 2012 program (Mountain Desert region – Arizona, Colorado, and New Mexico) has named the company’s President and CEO, Thomas Sandgaard, as one of the top three finalists for this coveted award.

Only the top innovators, who have shown the ability to deliver financial performance as well as a strong dedication both to the business and the communities in which the business operates, are selected each year for recognition as outstanding entrepreneurs. Needless to say, this is a huge boon both for the company and for Mr. Sandgaard, who was selected by the independent panel of judges, and who will be on hand June 28 at the Seawell Ballroom (Denver Center for the Performing Art) gala awards ceremony.

While eager to win this crowning achievement, ZYXI’s top man knows that it is the hard work, dedication, and constant drive to excel by the entire company team, which has propelled Zynex to its position of success thus far. From rather humble beginnings in 1996, to today handling all aspects of engineering, manufacturing, marketing, and selling the wide array of (chiefly electrotherapy) pain managing and rehabilitation devices the company offers, ZYXI has had quite the meteoric rise in the medical device industry. Today the company’s fully developed line of FDA-cleared products is seen all over the world.

ZYXI consists of three divisions, each of which is dedicated to a specific area: Zynex Medical, Zynex Monitoring Solutions, and Zynex NeuroDiagnostics. Zynex NeuroDiagnostics for instance, is responsible for the superb NeuroMove device, something stroke and spinal cord injury sufferers could have only dreamt of decades ago. This strong technical platform shows abundant promise in a variety of markets and the company is rapidly moving to aggress the parallel EMG, EEG, auditory, sleep pattern, and nerve conductivity (diagnosing neurological disorders) device spaces via ongoing development of the portfolio of technology, as well as shrewd acquisitions of identified technologies with serious potential.

This will mark the 26th annual Ernst & Young Entrepreneur Of The Year award, a symbol that has come to stand for as the par excellence metric whereby to judge the potential, vision, and leadership of the best and brightest entrepreneurs. The award is a true, unique hallmark, standing as the only global award of its kind for recognizing the most dynamic and capable businesses in over 140 cities and 50 countries worldwide, driving that recognition via an ingeniously localized model (having regional, national, and also global awards in the program).

Regional winners get kicked up to the nationals and announcements will be made for the Ernst & Young National Entrepreneur of the Year Overall Award, this Nov 17, at the awards ceremony in Palm Springs, CA. The awards themselves mark a culmination of the larger Ernst & Young Strategic Growth Forum, a national assemblage of high-growth companies and market leaders.

The Entrepreneur of the Year Awards are nationally funded by SAP America and the Ewing Marion Kauffman Foundation, and are founded/produced by Ernst & Young LLP, with localized sponsorship in the Mountain Desert region coming from a variety of sources, including ADP, CliftonLarsonAllen, The Denver Business Journal, Faegre Baker Daniels, JohnstonWells Public Relations, and Scherzer International. Ernst & Young is recognized as a global leader in advisory, transaction, and tax services, as a global organization of firms, serving just about every industry you can think of.

Quite the major coup for ZYXI, which has already established a solid reputation in the medical device space and now looks to go even further after being recognized via CEO Sandgaard for exceptional performance in the space.

For more information about today’s announcement, or to learn more about Zynex, Inc., please click your way over to the company’s website at: www.ZynexMed.com

Let us hear your thoughts below:

Satcon Technology is a leading provider of utility-scale power conversion solutions for the renewable energy market. For over 27 years, the company has designed and delivered some of the most advanced and efficient energy systems for solar photovoltaic, stationary fuel cells, and energy storage systems.

The company today announced it has been selected by Western Wind and Lord Electric to supply 30 megawatts of its Equinox Prism Platform solution, a fully integrated multi-megawatt medium voltage building block, optimized for utility-scale photovoltaic installations. Western Wind and Lord Electric will deploy twenty 1.5 megawatt Equinox Prism Platforms to power the second largest photovoltaic plant in Puerto Rico.

The Equinox Prism Platform is a turnkey utility-grade multi-megawatt solution, complete with factory-integrated step-up transformers, disconnect switches, and power conversion electronics. The factory-integrated solution leverages Satcon’s next-generation Equinox photovoltaic inverters with 98.5 percent peak efficiency and the industry’s widest thermal operating range. This delivers the highest levels of performance with low installation cost, giving it the industry’s lowest levelized cost of energy.

All Prism Platform solutions include EDGE Adaptive Control Architecture, enabling instant voltage stabilization, frequency control, and dynamic grid support. This architecture secures the continuous operation of the photovoltaic plant in the event of ground faults and achieves the performance guidelines established by the German Association of Energy and Water Industries.

For additional information about Satcon Technology Corporation and its products, please visit the company’s website at www.satcon.com

Let us hear your thoughts below:

Today, Hooper Holmes announced that it has expanded its relationship with NBC National Marketing, Inc. (NBCNM) to serve as its provider of management services. NCBNM is a premier National Marketing Organization within the life insurance industry.

“NBCNM realizes the breadth of services available through Hooper Holmes, and after working with their team of professionals, it was obvious that we could not provide the services to our members with near the effectiveness and efficiency as Hooper Holmes,” said Jim Wolfe, NBCNM member. “There are other entities in our industry that can provide similar services, but Hooper Holmes has committed valuable resources to make sure our system is one of the best in the industry.”

In 2011, NBCNM sought a centrally-managed support function to provide administrative sales support and application processing services to its member offices. NBCNM and Hooper Holmes began a pilot program which consisted of several core carriers. Supported by a team of brokerage-trained customer service representatives, the case management process was designed with the goal of expediting the submission-to-commission process, improving the quality of new business submissions, and improving overall placement ratios. Consistent quality performance has now led NBCNM to adopt Hooper Holmes for other key carriers.

Dan Dodson, Hooper Holmes’ Senior Vice President of Life Insurance, remarked, “We are excited about the expanded partnership with NBCNM, which underscores our ability to deploy our services and industry experience to better serve our customers. NBCNM has been a great partner, and we are proud of the results that they have experienced with our team. As NBCNM looks to expand its footprint in the marketplace and provide superior service to its members, we look forward to playing an important role with them.”

Let us hear your thoughts below:

There I was sitting in my living room wondering where to begin. We had purchased a couch two weeks ago and delivery was in two days. I thought it would be a good idea to really clean up. I had done this about 4 years ago and now seemed like the perfect time again.

Fortunately, a friend of the family who has an eye of organizing had been helping me. So here I was with boxes everywhere; boxes to go to storage and others still yet to be broken down into categories.

Now I was in complete overwhelm stuck wondering what to do next. My mind was in a whirl. Can you relate? Is any of this resonating with you?

When I catch myself during these times, I’ve trained myself to shift the situation by ADDing Perspective. Until you can become aware of what’s happening, you’ll most likely move directly into "Brain Freeze." As one of my clients said, "I know the overwhelm is consuming me but I can’t seem to do anything about it."

You can! As you know, ADD is situational so too Life is situational. In this situation, the burst of adrenaline has triggered one of my symptoms under stress – overwhelmed with details. Overwhelm is some form of fear. The fear is always related to something we just don’t understand. What we don’t understand may be the whole notion of brain freeze and what you can do when you find yourself in the midst of it.

The following is an exercise to unlock your "brain freeze" and move from overwhelm to overcome; from reaction to action.

1. Practice recognizing when and in what situations you become in my case, overwhelmed. Once you do, say out loud, "I’m overwhelmed! Good! At least I know I am." This moves you from focusing on what is not working to what works: from challenge to success; from a victim, blaming others, yourself, the circumstances to a hero accepting responsibility. This puts you firmly in charge.

2. Brain freeze is a bio-neurological set back. Do not take it personally. You’re brain chemistry is rattling the cage. Take a moment to calm the agitation.

Give yourself a break literally. Take 1 – 5 minute break. VISUALIZE yourself with your completed project. In my case, my new couch at home. My older couch finding a new home. Everything stored and in it’s perfect place.

3. Once there, look around. What do you see? What do you hear? What could you smell, touch, and/or taste. Most importantly, how do you feel?

4. Breathe this in and smile. Take a deep breath and smile. By this time, you just might find that your brain has unlocked. Once your brain has unlocked, you’ll be able to prioritize, decide what’s next and get moving closer to your goal.

5. Now, take one item and only one item and complete the task. It doesn’t matter which item. The action of choosing one and completing it creates "success momentum."

Learn to focus on one activity at a time. Do it the best you can by remembering what works for you and practice taking small steps over and over. You will find that this simple exercise is translatable to so many other situations. You can move from being overwhelmed and reactive to getting what you love you really want.

Step by step you move closer to personal clarity and personal happiness.

Free directory submission

DecisionPoint Systems, Inc., a provider of enterprise mobility and RFID systems, today posted its first-quarter results for the three months ended March 31, 2012, reflecting an increase in sales and a narrowed quarterly loss.

Revenue was $17.8 million, compared to $12.8 million for the same period a year ago.

Gross profit was $3.8 million, compared to $2.3 million for the same period of 2011; gross profit margin was 21.1%, compared to 18.2% for the same period a year ago.

DecisionPoint reported a net loss of approximately $459,000, or a loss of $0.06 per share, compared to a net loss of $1.65 million, or $0.38 per share, in the same period a year ago.

As of March 31, 2012, the company had $5.1 million available under its revolving credit facility and a cash balance of approximately $0.5 million. The company reduced its term loan down to $1.75 million from $2.0 million at December 31, 2011.

“Strong execution and new product introductions led to record revenue and gross margin expansion in the first quarter of 2012,” Nicholas Toms, CEO of DecisionPoint stated in the press release. “Our field mobility solutions continue to gain traction with our wireless carrier partners and customers. The pipeline of opportunities in our retail and warehouse and distribution segments continues to expand. Our improving utilization and continuing focus on cost control combined with the ongoing shift in our revenue mix in favor of software and professional services resulted in gross margin gains that we believe are sustainable going forward.”

Toms reports that the company’s tablet-based assisted shopping solution continues to generate revenue and is gaining acceptance among consumers; combined with recently introduced packaged solutions to be sold through carrier partners, the company reaffirms its guidance that revenue will grow more than 25 percent in 2012.

“Retail solution sales have continued to bounce back as the industry is in the beginning stages of a technology upgrade that will enhance retailers’ own competitiveness,” Toms stated.

For more information visit www.decisionpt.com

Let us hear your thoughts below:

Vision Industries’ recent announcement that it has finalized a purchase order agreement with Total Transportation Services, Inc. (TTSI) represents a major step for the Gardena, California, company. Vision is a developer of zero emission electric/hydrogen hybrid powered vehicles and turnkey hydrogen fueling systems. The agreement with TTSI, one of the largest delivery carriers in Los Angeles and the Port of Long Beach, calls for an initial purchase from Vision of 100 Tyrano Class 8 Trucks, the nation’s first street legal zero emission Class 8 hydrogen/electric hybrid GVWR (Gross Vehicle Weight Rating) truck. The agreement also allows TTSI to purchase an additional 300 Vision trucks, which would bring the total value of the contract to approximately $108 million.

Vision’s proprietary electric/hydrogen hybrid drive system combines the acceleration of a battery powered electric vehicle with the extended range provided by a hydrogen fuel cell. The result is vehicles having superior pulling capabilities, extended range, and lower lifetime cost of ownership. On a per mile basis, Vision heavy-duty Class 8 trucks are substantially less expensive to operate than diesel or natural gas powered trucks, offering a per mile cost savings of around 35% to 45%.

Vision CEO, Martin Schuermann, said of the agreement: “It has been a long road from our letter of intent signed a year ago to the closing of definite agreements. However, it was a very productive process in which we could identify specific needs of the trucking industry and translate those needs into our technology.”

The company also offers the Zero Emission Terminal Tractor (ZETT) electric/hydrogen hybrid, a terminal tractor designed to work a double shift before refueling. The ZETT is jointly developed by Vision and the Capacity of Texas.

For additional information on Vision Industries, visit the company’s website at www.VisionIndustriesCorp.com or www.VisionMotorCorp.com

Let us hear your thoughts below:

Maxygen announced that it will receive a $30.0 million payment from Bayer HealthCare LLC in connection with Bayer’s clinical development of a recombinant factor VIIa product candidate for the treatment of hemophilia. Maxygen sold the recombinant factor VIIa product candidate (previously designated by Maxygen as MAXY-VII) to Bayer in July 2008 for an upfront cash payment of $90.0 million. The purchase included all of its other hematology assets.

As of Monday, the additional $30.0 million contingent payment was based on the product candidate’s further development by Bayer and was also subject to the satisfaction of certain patent related conditions – all of which have been satisfied. Maxygen is not eligible for any further payments from Bayer related to these assets.

“The receipt of the full payment from Bayer represents a significant milestone in our continuing efforts to maximize returns for our stockholders,” said James Sulat, Chief Executive Officer of Maxygen. “We congratulate our colleagues at Bayer for this achievement and are pleased to see a program originally developed by Maxygen continue in clinical development.”

At March 31, 2012, Maxygen held approximately $155.3 million in cash, cash equivalents, and short-term investments. As of April 30, 2012, the company had 27,756,742 outstanding shares of common stock.

Let us hear your thoughts below:

VolitionRX, a life sciences company focused on developing blood-based diagnostic tests, today announced it has raised $1.0 million through the closure of a private placement of 582,510 shares at $1.75 per share. The company will use the proceeds in part to fund clinical trials of VolitionRX’s first NuQ™ test kits.

The funds are allocated to initial clinical trials of VolitionRX’s NuQ kits, blood-based diagnostic tests based on VolitionRX’s Nucleosomics technology; as well as for ongoing capital needs.

“We’re delighted that we have raised over $1 million, which will allow us to begin clinical trials of our tests, both in-house and in independent external trials in multiple centers across Europe and the rest of the world,” Cameron Reynolds, CEO of VolitionRX stated in the press release. “We are very encouraged by the promising results we’ve seen in initial validations of our NuQ tests and are hopeful that we’ll see similarly good results in larger clinical trials.”

The deal also entitles the holder to one share of common stock and a warrant to purchase a half share of common stock at $2.60 per share valid for four years.

In addition to the capital raised, 13 parties comprised of directors, employees, and consultants converted salaries and outstanding debt owed to them by VolitionRX on the same terms, for a total of $184,776.74.

For more information visit www.volitionrx.com

Let us hear your thoughts below:

Data Storage, a provider of cloud storage and cloud computing focused on data protection and business continuity solutions, today announced it has completed the first two phases of its three-phased expansion plan for its Waltham data center facility.

The company says the phase 1 and 2 completions more than triple the company’s existing footprint with the additional installation of IBM’s iSeries High Availability and Disaster Recovery server hardware and the new IBM iSeries Hosted Cloud solution.

In addition to the added High Availability and Disaster Recovery capacity upgrades, the expansion also greatly increases the company’s cloud-based offsite storage and data vaulting capabilities, which opens the door for opportunities within highly regulated industries such as finance and healthcare, where the need for storage on physical media is often inadequate, and exposes media to loss, theft, and degradation.

“Demand for our hosted solution offerings, especially in HA and DR services geared towards SMB customers, has grown significantly over the past year,” Matthew Grosso, executive vice president and CTO at Data Storage stated in the press release. “The completion of our phase 1 & 2 expansion in Waltham is just another step in our multi-year roadmap as we plan to meet greater demands for our High Availability and Disaster Recovery services. These expansions will enable us to roll out additional cloud services over the coming months.”

For more information visit www.datastoragecorp.com

Let us hear your thoughts below:

The risk off trade (sell everything) continued to extend to gold today as worries over the European debt crisis mounted. Continued political gridlock in Greece and problems in the Spanish banking system fed the doubts about the continent’s economic viability and that of its currency, the euro, in its current state. Gold moved higher earlier this year, along with other riskier assets like stocks, as investors thought the euro crisis was receding.

Spot gold hit a 4 ½ month low on Monday, dipping down to $1559.81 an ounce, its lowest point since December 2011. Gold closed in New York on Friday at $1,578.30. An analyst at Commerzbank, Daniel Briesemann, spoke about gold’s current weakness, “Gold is under severe pressure. The US dollar is being seen as a safe haven at the moment and as long as the dollar is appreciating against the euro this is clearly weighing on the gold price.”

With the current trend in place, most market analysts think that gold could test the $1500 an ounce level fairly soon. A dip below that price is also possible as long as the US dollar remains strong against the euro thanks to the European debt crisis. The euro fell to near a four-month low against the dollar, which rose against a basket of currencies. Since commodities like gold are priced in dollars, any rise in the dollar’s value usually implies weakness in commodity prices.

Also weighing on the sentiment for the precious metal, investors in gold futures and options cut their net long positions by 20 percent to the lowest level since December 2008. However, in the actual physical market for gold there is better news. Jewelry makers and buyers of gold bullion seem to be taking advantage of the fall in prices and are stepping up their buying. Physical gold dealers say that “supply is a bit tight in the physical market.”

Overall though, as long as the US dollar retains its current strength, gold prices should continue to drift lower in the days ahead.

Let us hear your thoughts below:

American Standard Energy reported a sharp year-over-year increase in oil and gas revenues in the first quarter of 2012. The company also confirmed progress on the exploration and development of onshore oil and gas assets.

American Standard Energy reported oil and gas sales of $5 million in the quarter ending March 31, 2012, up 109% from the $2.4 million recorded in the corresponding quarter of 2011. The company said that the increase was due to many factors, including higher production and higher realized prices for crude oil.

American Standard Energy reported production of 68,137 barrels of oil equivalent (BOE) in the most recent quarter, up 61% from the first quarter of 2012. The production level was higher due mostly to an acquisition of producing properties that the company made last year.

American Standard Energy continued to acquire acreage and increased its leasehold to 112,400 acres during the first quarter of 2012. The additional acreage was located in the Williston Basin and Permian Basin.

American Standard Energy spent $67.1 million in capital during the first quarter of 2012, with $57.4 million devoted to leasehold acquisitions, and the balance related to drilling and other development activities.

For more information on the company, go to www.asenergycorp.com

Let us hear your thoughts below:

Cover-All Technologies, a Delaware corporation and leading developer of sophisticated software solutions for the property and casualty insurance industry, announced its business intelligence (BI) solution, NexGen Business Intelligence, has been included in a Novarica report profiling insurance BI solutions. Novarica is a research and advisory firm focused on insurance technology strategy. The report, “Business Intelligence Solutions for U.S. Insurers 2012 (Q1),” profiles 19 vendors that currently offer BI solutions. The report describes the growing importance of BI and key areas of use by property/casualty insurance companies.

According to Martina Conlon, principal for Novarica’s insurance team and author of the report, many insurers today are recognizing the value of leveraging their internal data to improve their business, and they are investing accordingly. BI supplies historical, current, and predictive views of business operations by utilizing data to analyze information, make decisions, and manage performance.

The profile of Cover-All Technologies particularly notes NexGen Business Intelligence’s “…over 150 measures that can be sliced and diced using over 90 dimensions” and the fact that six insurers in the United States currently rely on the solution.

Cover-All’s BI was created to offer a proven, scalable, modern, and transformative solution for organizations seeking to unlock and leverage the value of their information. Cover-All Technologies feels that being featured in the Novarica report is a beneficial step in sharing with the industry all the benefits of its comprehensive insurance-specific BI solution, including features like prebuilt key performance indicators and drill down capabilities.

Since 1981, Cover-All Technologies has been a leading developer of sophisticated software solutions for the property and casualty insurance industry. The company was the first to deliver PC-based commercial insurance rating and policy issuance software. Cover-All is presently building on its reputation of offering quality insurance solutions, a knowledgeable staff, and superior customer service by creating new, innovative insurance solutions that leverage current technologies and give customers outstanding capabilities and value. The company continues its tradition of developing technology solutions that revolutionize the way the business of property and casualty insurance is conducted.

For more information, visit www.cover-all.com

Let us hear your thoughts below:

Quasar Aerospace Industries just announced that after a meeting of the majority of shareholders and the Board of Directors, the company has reduced the total number of shares authorized to four hundred and seventy-five million (475,000,000).

According to the press release issued this morning, Quasar Aerospace felt that the share reduction was prudent at this time. The company stated that it will continue to look to align its share structure and capitalization more appropriately; including the conversion terms of the preferred shares.

Quasar Aerospace also reminded the investment company of its announced conference call scheduled for Wednesday May 16, 2012, at 2:30 p.m. EDT. Those interested in participating should dial +1 (712) 432-0900, then enter the participant access code, 497592#, when prompted. Participants are encouraged to access the call at least five minutes before it is to begin. A playback of the call will be available later at +1 (712) 432-0990.

To learn more about the company, visit www.quasaraero.com

Let us hear your thoughts: Quasar Aerospace Industries, Inc. Message Board

Cardium Therapeutics has built a name for itself by capturing innovative biomedical technologies that emerge in the health sciences and regenerative medicine space, while simultaneously developing its own technology portfolio. By focusing on underserved demand and products/business opportunities with a clear path to monetization, CXM has been able to create a lightweight approach that harnesses all of the external partner, market, and technology strengths, while avoiding the cost structure pitfalls that plague many other operators in the same sector.

The envelope of medical business opportunities CXM has assembled to date includes the in-house MedPodium® Health Sciences healthy lifestyle product platform, and the tissue repair company, Cardium Biologics (therapeutics for wound treatment and cardiovascular indications). This granular approach to execution of the overall business model is extremely efficient from a capital standpoint, and the company derives maximum momentum from this advantage by actively pursuing new opportunities/technologies.

A perfect, recent example of how effective this strategy can be is seen in the exhibition of the company’s new, FDA-cleared, Excellagen® Wound Care Management Platform (a child of the company’s robust tissue engineering competencies), at the Spring 2012 SAWC (Symposium on Advanced Wound Care). Excellagen is CXM’s lead commercial product, a topical gel with exceptionally high molecular weight, made with a highly-refined bovine Type I fibrillar collagen formulation, and applied via easy-to-use, single-use, pre-filled syringes. The product (intended for physician use following surgical debridement procedures) is ideal for maladies like diabetic foot ulcers, and the recent SAWC showcasing really got the word out about this easy-to-control, pre-filled syringe, as well as the exceptionally biocompatible, optimal viscosity formulation that only requires applications every one to two weeks.

The company’s proprietary Gene Activated Matrix™ technology allows site-localized therapeutic levels of protein synthesis, and can be utilized in a variety of soft tissues. It is this type of brilliant technological refinement that has led to CXM’s ability to grow shareholder value, and the company is confident in this technology’s capacity for enhancing stimulation of processes like tissue repair, because the localized/site-specific production of therapeutically significant levels of DNA-driven proteins is seen as a driver of angiogenesis and tissue aggregation/formation.

CXM’s extensive market research identified the massively underserved demand from physicians for easy-to-use products that help shoulder the burden of an increasingly complex and hectic healthcare environment, developing Excellagen to surpass all other offerings in the space from a workflow standpoint, even making Excellagen ready-to-use (requires no thawing or mixing). Additionally the special formulation allows for only a thin layer to do the job, meaning a single syringe (0.5 cc), using the 24-gauge single-use flexible applicator tip that comes with the syringe, can cover wounds up to five square centimeters.

The company’s lead clinical candidate, Generx®, has tremendous potential for the initial target, advanced coronary artery disease (specifically the resulting myocardial ischemia, a heart disease where demand/supply of oxygen eventually leads to much worse conditions and heart attack). CXM is developing this innovative DNA-based angiogenic biologic via a cost-effective, international strategy, using Russian clinical development partner, bioRasi-Vendevia Group, to carry out the “ASPIRE” Phase III/Registration Study. Russia is the perfect place to do this as the incident rate in the population is very high and there is an abundance of potential cases where the costly alternative, angioplasty/stent procedures, are prohibitively expensive compared to something like Generx. This kind of DNA-based biologic technology has unquantifiable potential in regenerative medicine and there is great confidence for disease-modifying physiological response mechanisms stimulating growth and microvascular circulation.

Leveraging R&D investments by big pharma, institutional investors, and venture capital to springboard emergent tech into underserved markets, CXM is doing it all via shrewd partnerships that maximize both forward momentum and the underlying cost structure. The MedPodium portfolio has some attractive offerings as well, with a variety of science-based neutraceuticals designed for maximum quality and ease of use; the company’s Nutra-Apps® products are currently being rolled out over the web, as well as select target markets. With a three pronged front of developing products and diligent acquisitive activity, CXM is wielding an increasingly powerful capital structure that is grounded in an asset-based business strategy.

With zero outstanding debt and a huge market of some 1.3M (projected $80M in revenue at 10% domestic market penetration) patients in the U.S. alone with diabetic foot ulcers potentially treatable by their FDA-cleared Excellagen product, CXM is ideally-positioned as the U.S. patent system approaches the first major change in over 60 years with the coming Leahy-Smith America Invents Act (AIA, signed into law Sept 16, 2011). This move to a “first to file” system will throw a huge spotlight on small biotech firms like CXM, giving them increasing range and force in the market.

For more information on Cardium Therapeutics Inc., please visit the company’s website at: www.CardiumThx.com

Let us hear your thoughts below:

CytoSorbents, a critical care-focused company using blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses, today announced its CEO, Dr. Phillip Chan, was named as a finalist in the Ernst & Young Entrepreneur Of The Year® 2012 program, which recognizes entrepreneurs with demonstrated success in areas such as innovation, financial performance, and personal commitment.

Dr. Chan was selected by an independent judging panel comprised of previous winners, CEOs, private capital investors, and other regional business leaders.

Since his appointment as CytoSorbents CEO and president in 2009, Dr. Chan has taken initiatives to build the company into an emerging pioneer of advanced blood purification technologies, and is currently guiding the company through the transition from a development-stage company into an early commercialization stage company through the approval and early sales of its flagship product, CytoSorb®, in the EU.

As a board-certified internal medicine physician, Dr. Chan previously led healthcare and life science investments as Partner for the $80M NJTC Venture Fund and co-founded Andrew Technologies, a venture-backed medical device company.

Dr. Chan completed his residency at Harvard Medical School at the Beth Israel Deaconess Medical Center; received his MD/PhD from Yale University School of Medicine; and received his bachelor of science in cell and molecular biology with honors and distinction from Cornell University.

Awards will be presented at a special gala on June 27, 2012, at the Hyatt New Brunswick.

For more information visit www.cytosorbents.com

Let us hear your thoughts below: